Novo Group/Kelvin Holdco (Ellab)
Transaction details
The proposed acquisition by Echo BidCo A/S, an indirect wholly owned subsidiary of Novo Holdings A/S, of sole control of Kelvin HoldCo A/S, trading as Ellab, has been cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:10 July 2023
- Publication date:10 July 2023
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacture of electronics - C.26
- Simplified merger:Yes
- Outcome:Cleared
Documents
M.23.030 Merger AnnouncementPDF | 177 KBM.23.030 Merger Announcement PDF | 177 KB - Opens in new window
M.23.030 DeterminationPDF | 284 KBM.23.030 Determination PDF | 284 KB - Opens in new window
Timetable
Parties Involved
Echo BidCo A/S
Echo BidCo A/S is a wholly-owned subsidiary of Novo Holdings A/S, an indirect subsidiary of the Novo Nordisk Foundation. The Novo Nordisk Foundation is an established enterprise foundation, headquartered in Hellerup, Denmark. The Foundation's vision is to contribute to research and development that improves the lives of people and the sustainability of the planet. Novo Holdings A/S is responsible for managing the assets of the Novo Nordisk Foundation through investments in the life sciences and related area, and through investments in companies dedicated to medical and scientific research.
Ellab
Ellab provides validation and monitoring solutions and services used for measuring and documenting parameters such as temperature, pressure and carbon dioxide in biotech and pharma processes. Ellab is a portfolio company of the investment fund EQT Mid Market Europe, which is an EQT investment fund.
Contacts
Lewis O'Shea lewisoshea@ccpc.ie
